Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?
For now, Moderna may be a good stock to put on a watch list, but it's likely too risky and volatile for the vast majority of ...
Scientist verdict on new bat coronavirus in China and 'potential for human spillover'
Scientists have reacted to the discovery of a new coronavirus found in bats in a Wuhan lab close to the epicentre of Covid-19 ...
Novavax reports large quarterly revenue declines, rethinks its strategic direction
Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...
The New Republic on MSN55m
RFK Jr. Takes a Sledgehammer to Two Major Vaccine Developments
Multiple vaccine projects have been paused by the Department of Health and Human Services Secretary Robert F. Kennedy Jr. Kennedy paused a multimillion dollar project to create a new Covid-19 vaccine ...
RFK Jr. has long history of spreading false or misleading vaccine claims
Robert F. Kennedy Jr, the newly confirmed health secretary for the Trump administration who has called for sweeping policy ...
manilatimes2h
IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study
(NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today reported financial results for the year ended December 31, 2024 and highlighted recent ...
WXYZ2h
Advisory committee cancels flu shot meeting amid uncertainty in HHS leadership
A government advisory committee has canceled a meeting on flu shot recommendations, raising concerns amid shifts in ...
As measles cases mount in the US, what’s the situation worldwide?
The U.S. registered its first death from measles since 2015 this week, as a child who wasn’t vaccinated died in a measles ...
Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines
Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
Moderna stock falls amid review of bird flu vaccine funds
Moderna's reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...